Inflammation in Coronary Atherosclerosis: Insights into Pathogenesis and Therapeutic Potential of Anti-Inflammatory Drugs
Pharmaceuticals · 01.09.2023 · 16 (9) · 1242
DOI: 10.3390/ph16091242 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 01.09.2023. Verfasst von Clara Salles Figueiredo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Programa de Pós Graduação em Medicina e Saúde (Graduate Program in Medicine and Health), Federal University of Bahia, Salvador 40110-060, BA, Brazil. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Atherosclerosis is a lipid-driven immune-inflammatory disease that affects the arteries, leading to multifocal plaque development. The inflammatory process involves the activation of immune cells and various inflammatory pathways. Anti-inflammatory drugs have been shown to be effective in reducing cardiovascular events in individuals with coronary disease. However, their use is still limited due to concerns about long-term follow-up, cost-effectiveness, adverse effects, and the identification of the ideal patient profile to obtain maximum benefits. This review aims to improve the understanding of inflammation in coronary atherosclerosis and explore potential therapeutic interventions, encompassing both traditional and non-traditional anti-inflammatory approaches. By addressing these concepts, we seek to contribute to the advancement of knowledge about this type of treatment for coronary artery disease.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Programa de Pós Graduação em Medicina e Saúde (Graduate Program in Medicine and Health), Federal University of Bahia, Salvador 40110-060, BA, Brazil.
- Hospital Ana Nery, Salvador 40301-155, BA, Brazil.
ORCID-Profile: Clara Salles Figueiredo, Tainá Teixeira Viana
Zitieren
APA
Figueiredo, C. S., Roseira, E. S., Viana, T. T., Silveira, M. A. D., de Melo, R. M. V., Fernandez, M. G., Lemos, L. M. G., & Passos, L. C. S. (2023). Inflammation in Coronary Atherosclerosis: Insights into Pathogenesis and Therapeutic Potential of Anti-Inflammatory Drugs. Pharmaceuticals, 16(9), 1242. https://doi.org/10.3390/ph16091242
Vancouver
Figueiredo CS, Roseira ES, Viana TT, Silveira MAD, de Melo RMV, Fernandez MG, et al. Inflammation in Coronary Atherosclerosis: Insights into Pathogenesis and Therapeutic Potential of Anti-Inflammatory Drugs. Pharmaceuticals. 2023;16(9):1242. doi:10.3390/ph16091242
BibTeX
@article{Figueiredo2023,
author = {Figueiredo, Clara Salles and Roseira, Elias Soares and Viana, Tainá Teixeira and Silveira, Marcelo Augusto Duarte and de Melo, Rodrigo Morel Vieira and Fernandez, Miguel Godeiro and Lemos, Livia Maria Goes and Passos, Luiz Carlos Santana},
title = {Inflammation in Coronary Atherosclerosis: Insights into Pathogenesis and Therapeutic Potential of Anti-Inflammatory Drugs},
journal = {Pharmaceuticals},
year = {2023},
volume = {16},
number = {9},
pages = {1242},
doi = {10.3390/ph16091242}
}
EUVIMED